RESOURCES
Company News
Learn about Huateng's latest developments, industry news, and research findings
Choosing the Best Large Animal CRO: A Strategic Guide to IND Success (Beyond the Price Tag)
In the complex journey of drug discovery and biomedical research, the transition from the bench to human clinical trials is the most precarious stage of preclinical development. For pharmaceutical companies, selecting the right animal model is not just a regulatory box to check; it is a critical mission to validate the safety of promising drug candidates.
Tumor Xenograft Models in Cancer Research: The "Miniature Battlefield" in Mice
HuaTeng explore the role of CDX and syngeneic tumor models in preclinical cancer research. Learn how xenograft models using immunodeficient mice help evaluate chemotherapy and targeted therapies, while syngeneic models in immunocompetent mice support immuno-oncology discovery. Accelerate your drug development pipeline with validated in vivo platforms.
